SCM
HTGM

Stonepine Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Stonepine Capital Management’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,515
Closed -$323K – 21
2020
Q1 		$323K Sell
5,515
-20,921
-79% -$2.05M 0.34% 26
2019
Q4 		$3.34M Sell
26,436
-5,732
-18% -$776K 2.33% 13
2019
Q3 		$3.85M Buy
32,168
+16,693
+108% +$3.36M 3.73% 11
2019
Q2 		$4.62M Sell
15,475
-279
-2% -$116K 3.18% 12
2019
Q1 		$7.09M Buy
15,754
+888
+6% +$389K 4.08% 7
2018
Q4 		$6.8M Buy
14,866
+11,890
+400% +$7.37M 5.97% 7
2018
Q3 		$2.71M Sell
2,976
-6,408
-68% -$4.23M 1.58% 19
2018
Q2 		$5.51M Buy
+9,384
New +$6.12M 3.35% 11

Other funds holding HTGM

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KM
Kalos Management Alpharetta, Georgia $46.6M AUM 11.52% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return